Impact of dose reductions on efficacy of adjuvant abemaciclib for patients with high-risk early breast cancer (EBC): Analyses from the monarchE study

Basit Öğe Kaydı
dc.contributor.authorO'Shaughnessy, J.
dc.contributor.authorCicin, I.
dc.contributor.authorTesta, L.
dc.contributor.authorTolaney, S. M.
dc.contributor.authorHuober, J.
dc.contributor.authorGuarneri, V.
dc.contributor.authorJohnston, S. R. D.
dc.date.accessioned2024-06-12T11:20:23Z
dc.date.available2024-06-12T11:20:23Z
dc.date.issued2023
dc.departmentTrakya Üniversitesien_US
dc.descriptionAnnual Meeting of the European-Society-for-Medical-Oncology (ESMO) -- OCT 20-24, 2023 -- Barcelona, SPAINen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Soc Med Oncolen_US
dc.description.sponsorshipLilly and Companyen_US
dc.description.sponsorshipLilly and Company.en_US
dc.identifier.doi10.1016/j.annonc.2023.09.471
dc.identifier.endpageS293en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.startpageS293en_US
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2023.09.471
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25588
dc.identifier.volume34en_US
dc.identifier.wosWOS:001087480200266en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofAnnals Of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleImpact of dose reductions on efficacy of adjuvant abemaciclib for patients with high-risk early breast cancer (EBC): Analyses from the monarchE studyen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu